Cargando…

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis

Detalles Bibliográficos
Autores principales:	Miettunen, PM, Hamiwka, LA, Wade, AW, Midgley, JP, Grisaru, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334042/ http://dx.doi.org/10.1186/1546-0096-6-S1-P237

Ejemplares similares

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Involvement of Gut Microbiota in SLE and Lupus Nephritis
por: Mohd, Rozita, et al.
Publicado: (2023)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

The effect of juvenile systemic lupus erythematosus serum activated macrophages on a lupus nephritis model
por: Vernon, April S, et al.
Publicado: (2014)

Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE
por: Li, Chunzhen, et al.
Publicado: (2022)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study
por: Abdelkarim Aloub, Khansa Osama, et al.
Publicado: (2022)

Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
por: Lehman, Thomas JA, et al.
Publicado: (2014)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018)

Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review()
por: Pirone, Carmelo, et al.
Publicado: (2017)

SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus
por: Smith, Michael A., et al.
Publicado: (2019)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Low- Versus High-dose Cyclophosphamide in Class III/IV Lupus Nephritis: A Retrospective Study from South Asia
por: Wijayaratne, Dilushi Rowena, et al.
Publicado: (2023)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)

Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE)
por: Liebowitz, Jason, et al.
Publicado: (2018)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Canadian workplace experiences of systemic lupus erythematosus (SLE)
por: Cardwell, Francesca S, et al.
Publicado: (2021)

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
por: Williams-Hall, Rebecca, et al.
Publicado: (2022)

Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

O07 Managing relapsing and refractory lupus nephritis in juvenile systemic lupus erythematosus: a case report
por: Javed, Farhan, et al.
Publicado: (2021)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Class IV Lupus Nephritis in the Setting of Serologically Quiescent Disease and Normal Urine Sediment in a Patient with Late-Onset Systemic Lupus Erythematosus
por: Nnodum, Benedicta, et al.
Publicado: (2019)

O19 A Complex Case of Systemic Lupus Erythematosus with Class IV Lupus Nephritis in a 15-year-old Egyptian Girl
por: Malik, Dr Saadia, et al.
Publicado: (2020)

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
por: Hajji, Meriam, et al.
Publicado: (2023)

Biopsy-verified response of severe lupus nephritis to rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to NIH-protocol cyclophosphamide
por: van Vollenhoven, RF, et al.
Publicado: (2002)

SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus
por: Burt, Richard K, et al.
Publicado: (2003)

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)
por: Jiang, Wei, et al.
Publicado: (2014)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

44 Pediatric onset systemic lupus erythematosus (p-SLE)
por: Maher, Sheren
Publicado: (2022)

Colonic basidiobolomycosis in a patient with systemic lupus erythematosus (SLE)
por: Barahimi, Elham, et al.
Publicado: (2022)

An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management
por: Ameer, Muhammad Atif, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m52m1fo4vb48mrl98f5acifgcd